BRPI0510855A - medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis - Google Patents

medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis

Info

Publication number
BRPI0510855A
BRPI0510855A BRPI0510855-1A BRPI0510855A BRPI0510855A BR PI0510855 A BRPI0510855 A BR PI0510855A BR PI0510855 A BRPI0510855 A BR PI0510855A BR PI0510855 A BRPI0510855 A BR PI0510855A
Authority
BR
Brazil
Prior art keywords
estriol
pharmaceutically acceptable
oral administration
esters
medicament
Prior art date
Application number
BRPI0510855-1A
Other languages
English (en)
Inventor
Joachim Moormann
Walter Elger
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of BRPI0510855A publication Critical patent/BRPI0510855A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

MEDICAMENTO EM FORMA DE PELìCULA PARA MINISTRAçãO ORAL E USO DE ESTRIOL E/OU DE éSTERES DE ESTRIOL FARMACEUTICAMENTE ACEITáVEIS. A presente invenção refere-se a medicamentos com um formato de uma película os quais são ministrados oralmente, particularmente de uma forma bucal, e os quais são intencionados para o tratamento de perturbações de saúde climatéricas, os referidos medicamentos contendo estriol e/ou pelo menos um éster de estriol farmacologicamente aceitável, tanto só ou em combinação com pelo menos um gestágeno.
BRPI0510855-1A 2004-05-14 2005-05-06 medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis BRPI0510855A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004023984A DE102004023984A1 (de) 2004-05-14 2004-05-14 Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol
PCT/EP2005/004894 WO2005110358A2 (de) 2004-05-14 2005-05-06 Filmförmiges, oral zu verabreichendes arzneimittel, enthaltend estriol

Publications (1)

Publication Number Publication Date
BRPI0510855A true BRPI0510855A (pt) 2007-12-26

Family

ID=34977101

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0510855-1A BRPI0510855A (pt) 2004-05-14 2005-05-06 medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis

Country Status (16)

Country Link
US (1) US20070243217A1 (pt)
EP (1) EP1761242A2 (pt)
JP (1) JP2007537178A (pt)
KR (1) KR20070040753A (pt)
CN (1) CN1997349A (pt)
AR (1) AR048958A1 (pt)
AU (1) AU2005244409A1 (pt)
BR (1) BRPI0510855A (pt)
CA (1) CA2566325A1 (pt)
DE (1) DE102004023984A1 (pt)
IL (1) IL179014A0 (pt)
MX (1) MXPA06012890A (pt)
NO (1) NO20065657L (pt)
RU (1) RU2006140649A (pt)
TW (1) TW200536547A (pt)
WO (1) WO2005110358A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2714598A1 (en) * 2008-02-13 2009-08-20 Bayer Schering Pharma Aktiengesellschaft Drug delivery system with stabilising effect
BRPI0908477A2 (pt) * 2008-02-13 2018-03-27 Bayer Schering Pharma Ag sistema de distribuição de medicamento contendo estradiol
US20090269403A1 (en) * 2008-04-24 2009-10-29 Shaked Ze Ev Oral contraceptive dosage forms and methods of making such dosage forms
WO2010033832A2 (en) * 2008-09-19 2010-03-25 Evestra, Inc. Estriol formulations
DE102009007771B4 (de) * 2009-02-05 2012-02-16 Bayer Schering Pharma Aktiengesellschaft Bukkales Applikationssystem, 17α-Estradiol enthaltend
KR102044515B1 (ko) * 2019-08-20 2019-11-14 이영환 구강점막 부착력이 우수한 서방형 구강붕해용 필름 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0559240B1 (en) * 1987-09-24 2001-12-05 Jencap Research Limited Contraceptive packages containing oestrogen and progestin
ES2123666T3 (es) * 1992-03-21 1999-01-16 Entec Aplicacion de estriol para la preparacion de un sistema terapeutico transdermico para tratar la osteoporosis climaterica.
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
DE19832169A1 (de) * 1998-07-17 2000-01-27 Jenapharm Gmbh Lokal anwendbare pharmazeutische Präparate zur Prophylaxe und Therapie atrophischer Erscheinungen in der Mundhöhle
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
DE19932603A1 (de) * 1999-07-13 2001-01-25 Gruenenthal Gmbh Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren
PT1611892E (pt) * 2000-01-18 2009-11-20 Bayer Schering Pharma Ag Composições farmacêuticas compreendendo drospirenona

Also Published As

Publication number Publication date
DE102004023984A1 (de) 2005-12-08
CN1997349A (zh) 2007-07-11
AR048958A1 (es) 2006-06-14
AU2005244409A1 (en) 2005-11-24
MXPA06012890A (es) 2007-07-19
EP1761242A2 (de) 2007-03-14
WO2005110358A2 (de) 2005-11-24
WO2005110358A3 (de) 2007-03-15
KR20070040753A (ko) 2007-04-17
IL179014A0 (en) 2007-03-08
TW200536547A (en) 2005-11-16
US20070243217A1 (en) 2007-10-18
JP2007537178A (ja) 2007-12-20
CA2566325A1 (en) 2005-11-24
NO20065657L (no) 2006-12-07
RU2006140649A (ru) 2008-05-27

Similar Documents

Publication Publication Date Title
JP2010525050A5 (pt)
CY1110495T1 (el) Χρηση ενος αγωνιστη υποδοχεα nmda για τη θεραπεια εμβοης που προκαλειται απο κοχλιακη διεγερτοτοξικοτητα
BRPI0518622A2 (pt) usos de antagonistas de receptor do tipo 1 de interleucina-1(il-1r1) para a fabricaÇço de um medicamento para o tratamento de uma doenÇa respiratària; composiÇço farmacÊutica que compreende um antagonista do il-1r1 e um veÍculo fisiologicamente aceitÁvel e dispositivo de liberaÇço de medicamento
BRPI0716439B8 (pt) sistemas de liberação farmacêutico compreendendo flibanserina, processo para preparação e uso dos mesmos
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
EP1909772A4 (en) TRANSDERMAL DRUG FORMULATION
JP2010503695A5 (pt)
BRPI0607549A2 (pt) sistemas de distribuição farmacêutica para fármacos hidrófobos e composições compreendendo os mesmos
ATE440598T1 (de) Analgesische zusammensetzung von topisch angewendeten, nichtsteroiden und entzündungshemmenden arzneimitteln und opioiden
ATE540680T1 (de) Pharmazeutische aripiprazol-zusammensetzungen
WO2006063189A3 (en) Multi-layered chewing gum tablet with quick disintegration layer
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
WO2009022821A3 (en) Combination preparation comprising inhibitor of hmg-coa reductase and aspirin and method for manufacturing the same
ATE426635T1 (de) Arzneimittelverabreichung
NO20073403L (no) Anvendelse av atazanavir til forbedring av farmakokinetikken til legemidler metabolisert av UGT1A1
WO2011028794A2 (en) Treatment of huntington's disease with cycloserine and an nmda receptor antagonist
WO2008109385A3 (en) Oral administration of a calcitonin
TW200603787A (en) Topical preparations containing ambroxol
WO2007123848A3 (en) Therapeutic compositions containing modified class i slrp proteins
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
JP2007119497A5 (pt)
WO2005010022A3 (en) Agonist polypeptide of receptor for zot and zonulin
BRPI0510855A (pt) medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
WO2005030132A3 (en) Therapeutic regimens for administering drug combinations

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]